PASSAGE BIO, INC. Earnings Per Share (Basic)
PASSAGE BIO, INC. (PASG) reported Earnings Per Share (Basic) of -$2.44 per share for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-03
- PASSAGE BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$2.44.
- PASSAGE BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$2.36.
- PASSAGE BIO, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$4.08.
- PASSAGE BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$2.44.
- PASSAGE BIO, INC. earnings per share, basic for fiscal 2023 was -$1.86.
- PASSAGE BIO, INC. earnings per share, basic for fiscal 2022 was -$2.50.
- PASSAGE BIO, INC. earnings per share, basic for fiscal 2021 was -$3.48.
- PASSAGE BIO, INC. earnings per share, basic for fiscal 2020 was -$2.91.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.44 S-4/A · filed 2026-09-03 | -$4.80 S-4/A · filed 2026-09-03 | -$8.87 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$11.31 derived: net income ÷ weighted average shares · filed 2026-09-03 | ||||
| 2026-03-31 | -$2.36 S-4 · filed 2026-07-21 | -$6.43 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$8.87 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$11.84 derived: net income ÷ weighted average shares · filed 2026-09-03 | ||||
| 2025-12-31 | -$4.08 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$6.52 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$9.48 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$14.35 S-4/A · filed 2026-09-03 | ||||
| 2025-09-30 | -$2.44 10-Q · filed 2025-11-10 | -$5.40 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$10.26 10-Q · filed 2025-11-10 | -$14.30 derived: net income ÷ weighted average shares · filed 2026-09-03 | ||||
| 2025-06-30 | -$2.96 S-4/A · filed 2026-09-03 | -$7.83 S-4/A · filed 2026-09-03 | -$11.87 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$18.01 derived: net income ÷ weighted average shares · filed 2026-09-03 | ||||
| 2025-03-31 | -$4.87 S-4 · filed 2026-07-21 | -$0.25 10-Q · filed 2025-05-13 | -$8.91 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$15.05 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$20.14 derived: net income ÷ weighted average shares · filed 2026-09-03 | |||
| 2024-12-31 | -$4.04 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$10.18 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$15.27 derived: net income ÷ weighted average shares · filed 2026-09-03 | -$21.04 S-4/A · filed 2026-09-03 | -$1.07 10-K · filed 2025-03-04 | |||
| 2024-09-30 | -$6.15 10-Q · filed 2025-11-10 | -$0.31 10-Q · filed 2024-11-13 | -$11.24 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$17.04 10-Q · filed 2025-11-10 | -$0.87 10-Q · filed 2024-11-13 | -$2.34 derived: net income ÷ weighted average shares · filed 2025-11-10 | ||
| 2024-06-30 | -$5.09 10-Q · filed 2025-08-12 | -$0.26 10-Q · filed 2024-08-08 | -$10.87 10-Q · filed 2025-08-12 | -$0.55 10-Q · filed 2024-08-08 | -$1.30 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.81 derived: net income ÷ weighted average shares · filed 2025-08-12 | ||
| 2024-03-31 | -$0.30 10-Q · filed 2025-05-13 | -$0.60 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.10 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.53 derived: net income ÷ weighted average shares · filed 2025-05-13 | ||||
| 2023-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$1.24 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$1.86 10-K · filed 2025-03-04 | ||||
| 2023-09-30 | -$0.49 10-Q · filed 2024-11-13 | -$0.93 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$1.56 10-Q · filed 2024-11-13 | -$2.06 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||||
| 2023-06-30 | -$0.44 10-Q · filed 2024-08-08 | -$1.06 10-Q · filed 2024-08-08 | -$1.56 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$2.05 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||||
| 2023-03-31 | -$0.63 10-Q · filed 2024-05-14 | -$1.12 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.62 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$2.34 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||||
| 2022-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2024-03-04 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-03-04 | -$1.71 derived: net income ÷ weighted average shares · filed 2024-03-04 | -$2.50 10-K · filed 2024-03-04 | ||||
| 2022-09-30 | -$0.49 10-Q · filed 2023-11-13 | -$1.22 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$2.01 10-Q · filed 2023-11-13 | -$2.95 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.73 10-Q · filed 2023-08-07 | -$1.52 10-Q · filed 2023-08-07 | -$2.46 derived: net income ÷ weighted average shares · filed 2023-08-07 | -$3.33 derived: net income ÷ weighted average shares · filed 2023-08-07 | ||||
| 2022-03-31 | -$0.79 10-Q · filed 2023-05-11 | -$1.73 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2.60 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$3.50 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||||
| 2021-12-31 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.81 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$2.71 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$3.48 10-K · filed 2023-03-06 | ||||
| 2021-09-30 | -$0.87 10-Q · filed 2022-11-10 | -$1.77 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.53 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$0.90 10-Q · filed 2022-08-04 | -$1.66 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | -$0.76 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | -$2.91 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |